Cases 41 - 50 of 3,614
Heald et al v. H-E-B, LP et al
as 1:2023cv00018
Plaintiff:
maria heald, jeffrey alexander heald, nicholas matthew heald and others
Defendant:
H-E-B, LP, Chattem, Inc., Boehringer Ingelheim Corporation and others
Cause Of Action: 28 U.S.C. § 1441 Petition for Removal- Personal Injury
Koutz v. GlaxoSmithKline, LLC et al
as 3:2023cv18321
Plaintiff:
David Koutz
Defendant:
GlaxoSmithKline, LLC, GlaxoSmithKline Holdings (Americas) Inc and GlaxoSmithKline PLC
Cause Of Action: 28 U.S.C. § 1407 Multidistrict Litigation
Moore v. Chattem, Inc. et al
as 3:2023cv20225
Plaintiff:
Brenda Rae Moore
Defendant:
Chattem, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Corporation and others
Cause Of Action: 28 U.S.C. § 1407 Multidistrict Litigation
Gibson v. Boehringer Ingelheim Pharmaceuticals, Inc et al
as 3:2023cv22230
Plaintiff:
John Gibson
Defendant:
Boehringer Ingelheim Pharmaceuticals, Inc, Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Martin v. GlaxoSmithKline PLC et al
as 3:2023cv19002
Plaintiff:
Sharon Martin
Defendant:
GlaxoSmithKline PLC, GlaxoSmithKline, LLC and GlaxoSmithKline Holdings (Americas) Inc
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Perry v. GlaxoSmithKline, LLC et al
as 3:2023cv20566
Plaintiff:
Brianne Perry
Defendant:
GlaxoSmithKline, LLC, GlaxoSmithKline Holdings (Americas) Inc. and GlaxoSmithKline PLC
Cause Of Action: 28 U.S.C. § 1407 Multidistrict Litigation
Dearduff v. Boehringer Ingelheim Pharmaceuticals, Inc et al
as 3:2023cv22221
Plaintiff:
Shannon Dearduff
Defendant:
Boehringer Ingelheim Pharmaceuticals, Inc, Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Coroporation and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Fahrenkamp v. Boehringer Ingelheim Pharmaceuticals, Inc et al
as 3:2023cv22231
Plaintiff:
Brannon Fahrenkamp
Defendant:
Boehringer Ingelheim Pharmaceuticals, Inc, Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Clay v. Boehringer Ingelheim Pharmaceuticals, Inc et al
as 3:2023cv22074
Plaintiff:
Rachel Clay
Defendant:
Boehringer Ingelheim Pharmaceuticals, Inc, Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation and others
Cause Of Action: 28 U.S.C. § 1346 Tort Claim
DAVE v. Boehringer Ingelheim Pharmaceuticals, Inc. et al
as 3:2023cv22065
Plaintiff:
BERNARD DAVE
Defendant:
Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation and others
Cause Of Action: 28 U.S.C. § 1346 Tort Claim
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
